中海石油化學(03983.HK)附屬與東方石化訂合營協議
中海石油化學(03983.HK)公布,全資附屬海洋石油富島及東方石化於8月19日就設立和經營合資公司訂立合資協議,根據合資協議,合資公司應從事生產、製造和銷售丙烯(月青)產品及甲基丙烯酸甲酯產品,註冊資本為3億元人民幣(下同),海洋石油富島及東方石化對合資公司註冊資本認繳的出資額分別為1.53億元及1.47億元。
由於中國海油為公司的控股股東,而東方石化為中國海油的全資附屬公司,故此根據上市規則中國海油為公司的關連人士,而東方石化為中國海油的聯繫人並為公司的關連人士。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.